Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

about

Biotinylated Bioluminescent Probe for Long Lasting Targeted in Vivo Imaging of Xenografted Brain Tumors in Mice.

P2860

Q38680686-02CBB38E-2204-40B8-B98A-C4E6626C7333

P2860

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

Item

http://www.wikidata.org/entity/Q35624259

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

@ast

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

@en

type

Item

label

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

@ast

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

@en

prefLabel

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

@ast

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

@en

P1476

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

@en

P2093

Alexander Liggett

http://www.w3.org/2001/XMLSchema#string

Gopal Ramamurthy

http://www.w3.org/2001/XMLSchema#string

James Basilion

http://www.w3.org/2001/XMLSchema#string

Kari Lavik

http://www.w3.org/2001/XMLSchema#string

P2860

Ternary Gd(III)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI.

An esterase-activated magnetic resonance contrast agent.

A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.

Mechanistic investigation of beta-galactosidase-activated MR contrast agents.

Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics.

Imaging beta-galactosidase activity in human tumor xenografts and transgenic mice using a chemiluminescent substrate.

GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo.

Expanding the utility of beta-galactosidase complementation: piece by piece.

Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance

Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.

P304

660-668

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/BC500597Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ann-Marie Broome

Ian S Kinstlinger

P577

2015-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273637664

http://www.w3.org/2001/XMLSchema#string

P698

25775241

http://www.w3.org/2001/XMLSchema#string

P932

4437618

http://www.w3.org/2001/XMLSchema#string

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

about

P2860

P2860

Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932